Search Results

Questions and Answers About Clozapine, Part 2: A Dialogue About Indications for Clozapine, Managing Adverse Effects, and More.

• Authors : Meyer, Jonathan M.

Subjects: DRUG therapy for schizophrenia; RISK factors of pneumonia; CONTINUING education units

• Source: Psychiatric Times; Jul2024, Vol. 41 Issue 7, p28-31, 4p

Record details

Questions and Answers About Clozapine: A Dialogue About the Use of Plasma Levels.

• Authors : Meyer, Jonathan M.

Subjects: DRUG therapy for schizophrenia; CONTINUING education units; PATIENT compliance

• Source: Psychiatric Times; Jun2024, Vol. 41 Issue 6, p27-29, 3p

Record details

Constipation Conundrum With Clozapine.

• Authors : Judge, Roopa Singh; Bourgeois, James A.

Subjects: ANEMIA diagnosis; DRUG therapy for schizophrenia; GASTRIC intubation

• Source: Psychiatric Times; Feb2024, Vol. 41 Issue 2, p23-25, 3p

Record details

Clozapine: Once-Daily or Divided Dosing?

• Authors : Miller, Brian

Subjects: DRUG therapy for schizophrenia; PREVENTION of drug side effects; TREATMENT effectiveness

• Source: Psychiatric Times; Apr2024, Vol. 41 Issue 4, p28-28, 1p

Record details

Clozapine REMS program changes monitoring, dispensing regs.

• Authors : Talsma, Julia

Subjects: *TRAINING; CLOZAPINE; HEALTH risk assessment

• Source: Drug Topics. Nov2015, Vol. 159 Issue 11, p40-42. 2p.

Record details

FDA Updates Clozapine REMS Program.

• Authors : Myshko, Denise

Subjects: PHARMACOLOGY; UNITED States. Food & Drug Administration; CLOZAPINE

• Source: Formulary Watch. 8/2/2021, p1-1. 1p.

Record details

Treatment of bipolar disorder: A focus on medication therapy for mania.

• Authors : Williams, Kristal L. (AUTHOR); Ruekert, Laura (AUTHOR); Lum, Cheen (AUTHOR)

Subjects: CLOZAPINE; THERAPEUTIC use of lithium; RISPERIDONE

• Source: Formulary. Mar2011, Vol. 46 Issue 3, p82-97. 13p. 1 Color Photograph, 1 Chart.

Record details

FDA Pauses Clozapine REMS Program.

• Authors : Myshko, Denise

Subjects: UNITED States. Food & Drug Administration; RISK assessment; CONTINUUM of care

• Source: Formulary Watch. 11/25/2021, p1-1. 1p.

Record details

FDA Updates Clozapine REMS Program.

Subjects: NEUTROPENIA; UNITED States. Food & Drug Administration; RISK assessment

• Source: Formulary Watch. 7/30/2021, p1-1. 1p.

Record details

Clozapine-Induced Weight Gain: Is It Dependent on Dose?

• Authors : Miller, Brian

Subjects: PSYCHOSES; AGE distribution; TREATMENT duration

• Source: Psychiatric Times; Jun2023, Vol. 40 Issue 6, p38-38, 1p

Record details